Patent Litigation Surge in New Jersey: Drugmakers Ramp Up Legal Efforts to Block Generics

The District of New Jersey has seen a noticeable increase in patent litigation as drugmakers strive to prevent the release of generic versions of their drugs. In November alone, 29 patent lawsuits were filed, marking a significant rise compared to the previous monthly average of 18 suits from December 2023 to November 2024. This surge highlights the ongoing legal battles as generic drug manufacturers plan to introduce cost-effective alternatives to well-known pharmaceuticals. For further insights into this trend, more details can be explored here.